{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:17:45Z","timestamp":1776813465090,"version":"3.51.2"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313846"],"award-info":[{"award-number":["2018A030313846"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515012593"],"award-info":[{"award-number":["2021A1515012593"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2019A030317020"],"award-info":[{"award-number":["2019A030317020"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802257"],"award-info":[{"award-number":["81802257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871859"],"award-info":[{"award-number":["81871859"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772457"],"award-info":[{"award-number":["81772457"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172750"],"award-info":[{"award-number":["82172750"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172811"],"award-info":[{"award-number":["82172811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune checkpoint inhibitors (ICIs) have completely changed the approach pertaining to tumor diagnostics and treatment. Similarly, immunotherapy has also provided much needed data about mutation, expression and prognosis, affording an unprecedented opportunity for discovering candidate drug targets and screening for immunotherapy-relevant biomarkers. Although existing web tools enable biologists to analyze the expression, mutation and prognostic data of tumors, they are currently unable to facilitate data mining and mechanism analyses specifically related to immunotherapy. Thus, we effectively developed our own web-based tool, called Comprehensive Analysis on Multi-Omics of Immunotherapy in Pan-cancer (CAMOIP), in which we are able to successfully screen various prognostic markers and analyze the mechanisms involved in biomarker expression and function, as well as immunotherapy. The analyses include information relevant to survival analysis, expression analysis, mutational landscape analysis, immune infiltration analysis, immunogenicity analysis and pathway enrichment analysis. This comprehensive analysis of biomarkers for immunotherapy can be carried out by a click of CAMOIP, and the software should greatly encourage the further development of immunotherapy. CAMOIP provides invaluable evidence that bridges the information between the data of cancer genomics based on immunotherapy, providing comprehensive information to users and assisting in making the value of current ICI-treated data available to all users. CAMOIP is available at https:\/\/www.camoip.net.<\/jats:p>","DOI":"10.1093\/bib\/bbac129","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T08:12:52Z","timestamp":1647591172000},"source":"Crossref","is-referenced-by-count":101,"title":["CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer"],"prefix":"10.1093","volume":"23","author":[{"given":"Anqi","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}]},{"given":"Chang","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}]},{"given":"Ting","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}]},{"given":"Mengyao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-5349","authenticated-orcid":false,"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, P. R. China"}]},{"given":"Zaoqu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-2045","authenticated-orcid":false,"given":"Peng","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}]}],"member":"286","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"2022051813172440300_ref1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O\u2019Donnell","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"2022051813172440300_ref2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41698-020-00136-1","article-title":"Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy","volume":"4","author":"Huang","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"2022051813172440300_ref3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3389\/fphar.2020.01213","article-title":"Prognosis of lung adenocarcinoma patients with NTRK3 mutations to immune checkpoint inhibitors","volume":"11","author":"Niu","year":"2020","journal-title":"Front Pharmacol"},{"key":"2022051813172440300_ref4","doi-asserted-by":"crossref","first-page":"105028","DOI":"10.1016\/j.phrs.2020.105028","article-title":"Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer","volume":"159","author":"Lin","year":"2020","journal-title":"Pharmacol Res"},{"key":"2022051813172440300_ref5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat Genet"},{"key":"2022051813172440300_ref6","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-16-3556","article-title":"Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma","volume":"77","author":"Prat","year":"2017","journal-title":"Cancer Res"},{"key":"2022051813172440300_ref7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1200\/JCO.2017.75.3384","article-title":"Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing","volume":"36","author":"Rizvi","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2022051813172440300_ref8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41598-019-57218-9","article-title":"Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer","volume":"10","author":"Hwang","year":"2020","journal-title":"Sci Rep"},{"key":"2022051813172440300_ref9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"2022051813172440300_ref10","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2012.44.3762","article-title":"Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy","volume":"31","author":"Ulloa-Montoya","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2022051813172440300_ref11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"2022051813172440300_ref12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","article-title":"Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma","volume":"24","author":"Auslander","year":"2018","journal-title":"Nat Med"},{"key":"2022051813172440300_ref13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"2022051813172440300_ref14","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.7150\/thno.49451","article-title":"An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer","volume":"10","author":"Sui","year":"2020","journal-title":"Theranostics"},{"key":"2022051813172440300_ref15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.5858\/arpa.2015-0544-OA","article-title":"Development of a prototype immunohistochemistry assay to measure programmed death ligand-1 expression in tumor tissue","volume":"140","author":"Dolled-Filhart","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"2022051813172440300_ref16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.20892\/j.issn.2095-3941.2016.0009","article-title":"Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and\/or prognostic in non-small cell lung cancer?","volume":"13","author":"Mino-Kenudson","year":"2016","journal-title":"Cancer Biol Med"},{"key":"2022051813172440300_ref17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41591-019-0645-6","article-title":"Biomarkers for neoadjuvant checkpoint blockade response in urothelial cancer","volume":"25","author":"Ghatalia","year":"2019","journal-title":"Nat Med"},{"key":"2022051813172440300_ref18","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N Engl J Med"},{"key":"2022051813172440300_ref19","doi-asserted-by":"crossref","first-page":"630773","DOI":"10.3389\/fimmu.2021.630773","article-title":"Effect of NCOR1 mutations on immune microenvironment and efficacy of immune checkpoint inhibitors in patient with bladder cancer","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"key":"2022051813172440300_ref20","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/ijc.32002","article-title":"Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels","volume":"144","author":"Endris","year":"2019","journal-title":"Int J Cancer"},{"key":"2022051813172440300_ref21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.21037\/tlcr.2018.08.02","article-title":"Methods of measurement for tumor mutational burden in tumor tissue","volume":"7","author":"Mel\u00e9ndez","year":"2018","journal-title":"Transl lung cancer Res"},{"key":"2022051813172440300_ref22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00262-020-02668-8","article-title":"ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer","volume":"70","author":"Zhang","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"2022051813172440300_ref23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00428-015-1892-7","article-title":"Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases","volume":"468","author":"Warth","year":"2016","journal-title":"Virchows Arch"},{"key":"2022051813172440300_ref24","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fimmu.2020.02039","article-title":"Crosstalk Between the MSI status and tumor microenvironment in colorectal cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Front Immunol"},{"key":"2022051813172440300_ref25","first-page":"675","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume-title":"Nat Biotechnol","author":"Goldman","year":"2020"},{"key":"2022051813172440300_ref26","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2022051813172440300_ref27","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"2022051813172440300_ref28","doi-asserted-by":"crossref","first-page":"D746","DOI":"10.1093\/nar\/gkv1045","article-title":"Expression Atlas update\u2013an integrated database of gene and protein expression in humans, animals and plants","volume":"44","author":"Petryszak","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2022051813172440300_ref29","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2022051813172440300_ref30","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2022051813172440300_ref31","article-title":"Web application teaching tools for statistics using R and shiny","year":"2016"},{"key":"2022051813172440300_ref32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2022051813172440300_ref33","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2022051813172440300_ref34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2017-03-735654","article-title":"The NCI Genomic Data Commons as an engine for precision medicine","volume":"130","author":"Jensen","year":"2017","journal-title":"Blood"},{"key":"2022051813172440300_ref35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"2022051813172440300_ref36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"2022051813172440300_ref37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"2022051813172440300_ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-018-1612-0","article-title":"The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens","volume":"20","author":"Repana","year":"2019","journal-title":"Genome Biol"},{"key":"2022051813172440300_ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00073","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"2022051813172440300_ref40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"2022051813172440300_ref41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"2022051813172440300_ref42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","article-title":"EPIC: a tool to estimate the proportions of different cell types from bulk gene expression data","volume":"2120","author":"Racle","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2022051813172440300_ref43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"2022051813172440300_ref44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.mie.2019.05.056","article-title":"Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quan TIseq","volume":"636","author":"Plattner","year":"2020","journal-title":"Methods Enzymol"},{"key":"2022051813172440300_ref45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"2022051813172440300_ref46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/157489307780618231","article-title":"Gene set enrichment analysis (GSEA) for interpreting gene expression profiles","volume":"2","author":"Shi","year":"2007","journal-title":"Curr Bioinform"},{"key":"2022051813172440300_ref47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinform"},{"key":"2022051813172440300_ref48","doi-asserted-by":"crossref","first-page":"107327482097666","DOI":"10.1177\/1073274820976665","article-title":"Alterations in TP53 are a potential biomarker of bladder cancer patients who benefit from immune checkpoint inhibition","volume":"27","author":"Lyu","year":"2020","journal-title":"Cancer Control"},{"key":"2022051813172440300_ref49","doi-asserted-by":"crossref","first-page":"645862","DOI":"10.3389\/fphar.2021.645862","article-title":"Catenin alpha-2 mutation changes the immune microenvironment in lung adenocarcinoma patients receiving immune checkpoint inhibitors","volume":"12","author":"Wen","year":"2021","journal-title":"Front Pharmacol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/3\/bbac129\/43746993\/bbac129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/3\/bbac129\/43746993\/bbac129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T11:02:23Z","timestamp":1726830143000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbac129\/6565619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5,13]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbac129","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.10.459722","asserted-by":"object"}]},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5]]},"published":{"date-parts":[[2022,4,9]]},"article-number":"bbac129"}}